Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition.

Cruyssen, Bert J. Vander; Durez, Patrick; Westhovens, Rene; Van den Bosch, Filip; Mielants, Herman; De Clerck, Luc; Peretz, Ann; Malaise, Michel; Verbruggen, Leon; Vastesaeger, Nathan; Geldhof, Anja; De Keyser, Filip

Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition.

Cruyssen, Bert J. Vander

;

Durez, Patrick

;

Westhovens, Rene

;

Van den Bosch, Filip

;

De Keyser, Filip

;et.al.

(2006) 70th Annual Scientific Meeting of the American-College-of-Rheumatology/41st Annual Scientific Meeting of the Association-of-Rheumatology-Health-Professionals — Location: Washington (Dc) (10.November.2006)

Files

No attached file found for this publication.

Details

Authors

Cruyssen, Bert J. Vander
Author
Durez, PatrickUCLouvain
Author
Westhovens, Rene
Author
Van den Bosch, Filip
Author
De Keyser, Filip
Author

Affiliations

Citations

APA
Chicago
FWB

Cruyssen, B. J. V., Durez, P., Westhovens, R., Van den Bosch, F., Mielants, H., De Clerck, L., Peretz, A., Malaise, M., Verbruggen, L., Vastesaeger, N., Geldhof, A., & De Keyser, F. (2006). Four year follow-up of infliximab in rheumatoid arthritis patients refractory to multiple dmard treatment: Long-term clinical effect and prediction of attrition. Arthritis & Rheumatism, 54(9), S234-S235. https://hdl.handle.net/2078.5/139559 (Original work published 2006)